Article info
Ischemic stroke
Original research
Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke
- Correspondence to Dr Raul G Nogueira, Emory Faculty Office Building, 80 Jesse Hill Dr. SE, Room 398, Atlanta, GA 30303, USA; rnoguei{at}emory.edu
Citation
Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke
Publication history
- Received April 5, 2012
- Accepted May 7, 2012
- First published June 15, 2012.
Online issue publication
June 11, 2013
Article Versions
- Previous version (15 June 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions